FNA of misclassified primary malignant neoplasms of the thyroid: Impact on clinical management

Background: Fine needle aspiration (FNA) cytology is a popular, reliable and cost effective technique for the diagnosis of thyroid lesions. The aim of our study was to review cases of misclassified primary malignant neoplasms of the thyroid by FNA, and assess the causes of cytologic misdiagnosis and their impact on clinical management. Methods: Clinical data, FNA smears and follow-up surgical specimens of cases diagnosed with primary thyroid carcinoma were reviewed. Results: Of the 365 cases with a malignant diagnosis by FNA over a period of 11 years, nine (2.4 %) were identified with discrepant histologic diagnosis with regard to the type of primary thyroid malignancy. In addition, four cases were added from the consultation files of the Massachusetts General Hospital. Areas of difficulty contributing to misclassification included overlapping cytologic features (n = 6), rarity of tumors (n = 3), and sampling limitations (n = 4). Of the 13 cases, 12 underwent total or near total thyroidectomy and one patient had concurrent surgical biopsy. Measurement of serum calcitonin levels in one case, with an initial cytologic diagnosis of medullary carcinoma, prevented unnecessary lymph node dissection. Misclassification of medullary carcinoma as papillary carcinoma precluded lymph node dissection in one case. Further management decisions were based on the final histologic diagnosis and did not require additional surgery. Two cases of undifferentiated (anaplastic) thyroid carcinoma were misdiagnosed as papillary thyroid carcinoma. Both patients received total thyroidectomies, which may not otherwise have been performed. Conclusions: A small subset of primary malignant neoplasms of the thyroid may be misclassified with regard to the type of malignancy on FNA. The majority of primary malignant neoplasms diagnosed on FNA require thyroidectomy. However, initial cytologic misclassification of medullary carcinoma or undifferentiated carcinoma as other malignant neoplasms or vice versa may have an impact on clinical management.

[1]  D. Henderson,et al.  Intranuclear vacuoles in nonpapillary carcinoma of the thyroid. A report of three cases. , 1984, Acta cytologica.

[2]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[3]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[4]  V. Livolsi,et al.  Papillary thyroid carcinoma with nodular fasciitis-like stroma. Pitfalls in fine-needle aspiration cytology. , 1999, Archives of pathology & laboratory medicine.

[5]  M. Dottorini,et al.  Usefulness of fine‐needle aspiration in the diagnosis of thyroid carcinoma , 2000, Cancer.

[6]  D. Francis,et al.  Intranuclear cytoplasmic invaginations in a Hürthle-cell carcinoma of the thyroid. , 1983, Acta cytologica.

[7]  W. Taylor,et al.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. , 1987, Surgery.

[8]  M. Merino,et al.  The significance of the grooved nucleus in thyroid lesions. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  H. Gharib,et al.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  N. Agnantis,et al.  The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules. , 2005, In vivo.

[11]  S. Pilotti,et al.  The role of fine needle aspiration in the diagnosis of thyroid nodules: Analysis of 795 consecutive cases , 1992, Journal of surgical oncology.

[12]  A. Pinchera,et al.  Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  R. Kloos,et al.  Anaplastic thyroid cancer. , 2008, Endocrinology and metabolism clinics of North America.

[14]  M. Sack,et al.  Fine-needle aspiration of thyroid: an institutional experience. , 1998, Thyroid : official journal of the American Thyroid Association.

[15]  E. Bergstralh,et al.  Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? , 1998, Surgery.

[16]  D. Davey,et al.  Intranuclear cytoplasmic inclusions in aspirates of follicular neoplasms of the thyroid. A report of two cases. , 1984, Acta cytologica.

[17]  H. Gharib,et al.  Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal , 1993, Annals of Internal Medicine.

[18]  J. Chan,et al.  Mucin production in metastatic papillary carcinoma of the thyroid. , 1988, Human pathology.

[19]  M. Bäckdahl,et al.  Fine-needle biopsy cytology and DNA analysis. Their place in the evaluation and treatment of patients with thyroid neoplasms. , 1987, The Surgical clinics of North America.

[20]  H. Gharib,et al.  Evaluation of nodular thyroid disease. , 1988, Endocrinology and metabolism clinics of North America.

[21]  M. Zakowski,et al.  Cytopathology of insular carcinoma of the thyroid , 1999, Cancer.

[22]  C. Morrison,et al.  Aspiration Cytopathology of Metastatic Mucinous Papillary Thyroid Carcinoma , 2001, Modern Pathology.